Extraordinary General Meeting in Aerocrine AB
Aerocrine AB have today, 14 July 2015, held an extraordinary meeting. The following resolutions were made at the meeting. Annulment of resolution on the nomination committee At the Annual General Meeting held on 12 May 2015 it was resolved that the company's nomination committee shall consist of representatives from the four largest shareholders by voting powers and the Chairman of the Board. Circassia Pharmaceuticals plc holds more than 90 per cent of the shares and votes in the company and therefore the meeting resolved to annul the resolution on the nomination committee.